Dr. Spiegel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
HJF-DAIDS/NIAID/NIH
5601 Fishers Lane
North Bethesda, MD 20852Phone+1 240-292-4633
Education & Training
NYU Grossman School of MedicineResidency, Pediatrics, 1995 - 1999
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1992 - 1995
Freie University Berlin Faculty of MedicineClass of 1985
Certifications & Licensure
DC State Medical License 2001 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
Publications & Presentations
PubMed
- 36 citationsTenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in ...Lynda Stranix-Chibanda, Peter L. Anderson, Deborah Kacanek, Sybil G. Hosek, Sharon Huang
Clinical Infectious Diseases. 2021-10-05 - 30 citationsSafety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial.Joseph A. Politch, Susan Cu-Uvin, Thomas R. Moench, Karen T. Tashima, Jai G Marathe
Plos Medicine. 2021-02-03 - 29 citationsTenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trialMarla J. Keller, Lianna F. Wood, James M. Billingsley, Laurie L. Ray, Jessica Goymer
The Lancet. HIV. 2019-07-15
Grant Support
- ACTG 219c: Pediatric LATE Outcome Protocol, Version 30 HIV/AIDSNational Center For Research Resources2007–2008
- P1030: A Phase I/II Study Of Lopinavir/Ritonavir In HIV-1 Infected Infants <6National Center For Research Resources2006
- HIV Specific Immune Responses And Disease Progression In Pediatric HIV-1 InfectiNational Center For Research Resources2006
- ACTG 219c: Pediatric LATE Outcome Protocol, Version 40National Center For Research Resources2006
- Pactg P1006: The Effects Of Highly Active Antiretroviral Therapy (HAART)National Center For Research Resources2005–2006
- Pactg 351 Phase 1/11trial Of Cd4-1gg2 Hiv-Infected ChilNational Center For Research Resources2005
- Pactg 1045: Morphologic &Metabolic Abnormality In Hiv-Infect &Uninfect ChildNational Center For Research Resources2005
- Pactg 1030: Phase I/II Study Of Lopinavir/Ritonavir InNational Center For Research Resources2005
- Pactg 1010: Antiretroviral Therapy On Body CompositionNational Center For Research Resources2005
- P1025: Perinatal Core Protocol, Version 20National Center For Research Resources2005
- ACTG 219c: Pediatric LATE Outcomes Protocol, Version 40National Center For Research Resources2005
- Washington D.C. Consortium Pediatric AIDS Clinical TrialNational Institute Of Allergy And Infectious Diseases2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
